Modulation of Lymphocyte Function for Cancer Therapy: A Phase II Trial of Tremelimumab in Advanced Gastric and Esophageal Adenocarcinoma

被引：0
|
作者：
Ralph, Christy [1 ,2 ]
Elkord, Eyad [1 ]
Thistlethwaite, Fiona C. [1 ]
Burt, Debbie J. [1 ]
O'Dwyer, Jackie [1 ]
Stern, Peter L. [2 ]
Hawkins, Robert F.
机构：
[1] Christie NHS Fdn Trust, Paterson Inst Canc Res, Manchester, Lancs, England
[2] Univ Manchester, Paterson Inst Canc Res, Manchester, Lancs, England
来源：
JOURNAL OF IMMUNOTHERAPY | 2009年 / 32卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：960 / 961
页数：2
相关论文
共 50 条
  • [41] Palliative radiotherapy in symptomatic locally advanced gastric cancer: A phase II trial
    Tey, Jeremy
    Zheng, Huili
    Soon, Yu Y.
    Leong, Cheng N.
    Koh, Wee Y.
    Lim, Keith
    So, Jimmy B. Y.
    Shabbir, Asim
    Tham, Ivan W. K.
    Lu, Jiade
    CANCER MEDICINE, 2019, 8 (04): : 1447 - 1458
  • [42] PHASE-II TRIAL OF UFT IN ADVANCED COLORECTAL AND GASTRIC-CANCER
    MALIK, STA
    TALBOT, D
    CLARKE, PI
    OSBORNE, R
    REZNEK, R
    WRIGLEY, PFM
    SLEVIN, ML
    BRITISH JOURNAL OF CANCER, 1990, 62 (06) : 1023 - 1025
  • [43] A phase II trial of the Src kinase inhibitor saracatinib (AZD0530) in patients with metastatic or locally advanced gastric or gastro esophageal junction (GEJ) adenocarcinoma: a trial of the PMH phase II consortium
    Mackay, Helen J.
    Au, Heather J.
    McWhirter, Elaine
    Alcindor, Thierry
    Jarvi, Andrea
    MacAlpine, Katrina
    Wang, Lisa
    Wright, John J.
    Oza, Amit M.
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (03) : 1158 - 1163
  • [44] A phase II trial of the Src kinase inhibitor saracatinib (AZD0530) in patients with metastatic or locally advanced gastric or gastro esophageal junction (GEJ) adenocarcinoma: a trial of the PMH phase II consortium
    Helen J. Mackay
    Heather J. Au
    Elaine McWhirter
    Thierry Alcindor
    Andrea Jarvi
    Katrina MacAlpine
    Lisa Wang
    John J. Wright
    Amit M. Oza
    Investigational New Drugs, 2012, 30 : 1158 - 1163
  • [45] Phase Ib trial of Durvalumab plus tremelimumab with particle therapy for advanced HCC: DEPARTURE
    Makishima, Hirokazu
    Ogasawara, Sadahisa
    Koroki, Keisuke
    Wakatsuki, Masaru
    Takahashi, Asahi
    Kanzaki, Hiroaki
    Kobayashi, Kazufumi
    Inoue, Masanori
    Kiyono, Soichiro
    Nakamura, Masato
    Kanogawa, Naoya
    Kondo, Takayuki
    Nakamoto, Shingo
    Shiko, Yuki
    Ozawa, Yoshihito
    Inaba, Yosuke
    Kurokawa, Tomoya
    Hanaoka, Hideki
    Yamada, Shigeru
    Kato, Naoya
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S2129 - S2130
  • [46] Phase II trial of trimetrexate in advanced esophageal cancer: A Southwest Oncology Group Study
    Fleming, TR
    Brown, TD
    Ross, SW
    Macdonald, JS
    INVESTIGATIONAL NEW DRUGS, 1995, 13 (04) : 363 - 365
  • [47] A phase II trial of gemcitabine (gem) & cisplatin (cis) in advanced esophageal cancer (AEC).
    Scullin, P
    Millar, J
    Dunlop, D
    Price, A
    Cameron, D
    Phillips, H
    Wall, L
    Morrison, A
    Eatock, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 322S - 322S
  • [48] Phase II study of panitumumab plus irinotecan as second-line therapy for advanced esophageal adenocarcinoma
    Liu, Yang
    Zaidi, Ali H.
    Nason, Katie S.
    Egloff, Ann M.
    Ferris, Robert
    Jobe, Blair
    Yoon, Harry
    Forastiere, Arlene A.
    Gibson, Michael K.
    CANCER RESEARCH, 2012, 72
  • [49] PHASE-II TRIAL OF PIROXANTRONE IN METASTATIC GASTRIC ADENOCARCINOMA
    PAZDUR, R
    BREADY, B
    SCALZO, AJ
    BRANDOF, JE
    CLOSE, DR
    KOLBYE, S
    WINN, RJ
    INVESTIGATIONAL NEW DRUGS, 1994, 12 (03) : 263 - 265
  • [50] Adjuvant biochemical modulation therapy for advanced gastric cancer
    Adachi, S
    Kondo, T
    Todoroki, T
    Fukao, K
    PROGRESS IN GASTRIC CANCER RESEARCH 1997: PROCEEDINGS OF THE 2ND INTERNATIONAL GASTRIC CANCER CONGRESS, 1997, : 1507 - 1511
12345